Abstract:Introduction Adipose-derived stem cells (ADSCs) possess the potential of multi-differentiation which could differentiate into neuronal cells and Schwann cells under certain conditions. If we inoculate the ADSCs modified by Brain derived neurophic factor(BDNF) and Neurotrophin-3(NT-3)double genes on the silk fibroin/chitosan (SFCS), and transplant it into 2 mm pre-made spinal cord transection animal model, we can take advantage of the characteristic of ADSCs which could express BDNF and NT-3 stably after being double gene modified and the advantage of tissue engineering, we look forward to providing a new treatment method for spinal cord injury (SCI), which thereby could reduce SCI morbidity and mortality rate, so as to build up a solid theoretical foundation for the clinical treatment of SCI. Material and Methods According to the preliminary design, animal experiment is divided into seven groups: Group A: SFCS/ADSCs/Lenti-BDNF-GFP-NT-3-RFP, namely, BDNF and NT-3 double genes co-transfect ADSCs combining SFCS group; Group B: SFCS/ADSCs/Lenti-BDNF-GFP, namely, BDNF single gene transfect ADSCs combining SFCS group; Group C: SFCS/ADSCs/ Lenti-NT-3-RFP, namely, NT-3 single gene transfect ADSCs combining SFCS group; Group D: SFCS/ADSCs/Lenti-eGFP, namely, empty vector transfect ADSCs combining SFCS group; Group E:SFCS, namely, single SFCS group; Group F:only cut off spinal cord and without treatment; Group G: normal control group, just open the vertebral plate without any treatment. Group A, B, C, D and E transplant the scaffold into 2 mm spinal cord transection defect rat model. Group F cuts off spinal cord and makes 2 mm defect, Group G is normal group. Do a BBB scoring at 1 w, 4 w, 8 w and 12 w after surgery to analyze functional recovery, execute the rats 12 w later, take out the scaffolds, test them by HE staining, immunehistochemical staining (NSE, GAP-43, Caspase-3, GFAP), LFB staining, RT-PCR and Western blot, the purpose of which is to observe the effect of tissue engineering on the recovery of SCI. Results Group A (BDNF and NT-3 double genes modified ADSCs combining the use of SFCS group) has a better repair effect on rats spinal cord transection injury treatment, which reveals higher BBB scores, increased GAP-43 expression, more positive NSE cells, decreased expression of GFAP and Caspase-3. At the same time denser regenerating nerve fiber could move through the scaffold, and the most important thing is the repair effect of Group A is better than single gene modified Group B and Group C, which is better than Group D (empty vector transfect ADSCs combining SFCS group), which is better than Group E (single use SFCS), which is better than Group F (just cut off spinal cord and without treatment). Conclusion Under the guidance of tissue engineering method, ADSCs modified by BDNF and NT-3 double genes combining the use of SFCS can significantly reduce the inflammatory response after injury, inhibit scar hyperplasia and cell apoptosis and promote nerve fibers regeneration and the differentiation of ADSCs into neurons in vivo, so as to improve the repair effect of rat spinal cord transection injuries, which provides a new method for the treatment of SCI.

Comparison of the effect of adult neural stem cells derived from different origins in treatment of rat spinal cord injury

Comparison of adult neurospheres derived from different origins for treatment of rat spinal cord injury.

Comparison of Neural Stem Cells and Bone Marrow Mesenchymal Stem Cells Transplantation for Spinal Cord Injury

Timeliness of homologuous embryonic neural stem cells transplantation for spinal cord injury

Effects of Differentiated Versus Undifferentiated Adipose Tissue-derived Stromal Cell Grafts on Functional Recovery after Spinal Cord Contusion

The treatment of spinal cord injury in rats using bone marrow-derived neural-like cells induced by cerebrospinal fluid

Comparison of Regenerative Effects of Transplanting Three-Dimensional Longitudinal Scaffold Loaded-Human Mesenchymal Stem Cells and Human Neural Stem Cells on Spinal Cord Completely Transected Rats.

Treatment of rats with spinal cord injury with transplanting human neural stem cells

An Experimental Study on the Treatment of Spinal Cord Injury in Rats by Tissue Engineering Method That Uses ADSCs Modified by BDNF and NT-3 Double Genes Combing the Use of SFCS

Transplantation of Neural Stem Progenitor Cells from Different Sources for Severe Spinal Cord Injury Repair in Rat.

Improvement of neurological function in rats with spinal cord injury after the transplantation of neural stem cells directly differentiated from bone marrow mesenchymal stem cells

The Survival and Differentiation of Bone Marrow Stromal Cells after Spinal Cord Injury in Rat with Intravenous Administration

Experimental Study on Neural Stem Cells Transplantation for Treating Spinal Cord Transection Injury

Stem Cell Transplantation at Different Time Points after Spinal Cord Injury for Behavioral Recovery in Rats

[Analysis of Chronergy for Treatment of Spinal Cord Injury with the Allogeneic Bone Mesenchymal Stem Cells (bmscs) Transplantation in Rats].

Treatment of Rat Spinal Cord Injury with Autologous Activated Schwann Cells Via Different Grafting Routes

Effect of free NgR-modified bone marrow stromal cell transplantation on axon regeneration after spinal cord injury

Experimental study on repairing spinal cord injury by human umbilical cord blood CD34+cell transplantation at different time points

Activated Schwann Cells Combined with Umbilical Cord Blood Mesenchymal Stem Cell Transplantation for Repair of Spinal Cord Injury

The Effect Following Transplantation of Fetal Human Neural Stem Cells in Spinal Cord Injured Rats

Allogeneic Neural Stem Cell Transplant Promotes Functional Recovery of Locomotion After Complete Transected Spinal Cord Injury Predominantly by Secreting Neurotrophic Factors